Importer of Controlled Substances Application: Rhodes Technologies, 22070 [2021-08539]

Download as PDF 22070 Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,2 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS.3 This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of §§ 201.10 and 210.8(c) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.8(c)). By order of the Commission. Issued: April 21, 2021. Lisa Barton, Secretary to the Commission. In accordance with 21 CFR 1301.34(a), this is notice that on March 15, 2021, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Tetrahydrocannabinols .......... Methylphenidate ..................... Oxycodone ............................. Hydromorphone ..................... Hydrocodone .......................... Morphine ................................ Opium, Raw ........................... Oxymorphone ........................ Poppy Straw Concentrate ...... BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–827] Importer of Controlled Substances Application: Rhodes Technologies Drug Enforcement Administration, Department of Justice. ACTION: Notice of application. AGENCY: Rhodes Technologies has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the SUMMARY: 2 All contract personnel will sign appropriate nondisclosure agreements. 3 Electronic Document Information System (EDIS): https://edis.usitc.gov. 18:01 Apr 23, 2021 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: Controlled substance [FR Doc. 2021–08654 Filed 4–23–21; 8:45 am] VerDate Sep<11>2014 issuance of the proposed registration on or before May 26, 2021. Such persons may also file a written request for a hearing on the application on or before May 26, 2021. Jkt 253001 Schedule 7370 1724 9143 9150 9193 9300 9600 9652 9670 I II II II II II II II II The company plans to import Opium, Raw (9600), and Poppy Straw Concentrate (9670) in order to bulk manufacture controlled substances in Active Pharmaceutical Ingredient (API) form. The company distributes the manufactured APIs in bulk to its customers. The company plans to import the other listed controlled substances for internal reference standards use only. The comparisons of foreign reference standards to the company’s domestically manufactured API will allow the company to export domestically manufactured API to foreign markets. William T. McDermott, Assistant Administrator. [FR Doc. 2021–08539 Filed 4–23–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–NEW] Agency Information Collection Activities; Proposed eCollection, eComments Requested; New Proposed Collection Exempt Chemical Preparations Application Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until June 25, 2021. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. SUMMARY: E:\FR\FM\26APN1.SGM 26APN1

Agencies

[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Page 22070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08539]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-827]


Importer of Controlled Substances Application: Rhodes 
Technologies

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Rhodes Technologies has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 26, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before May 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on March 15, 2021, Rhodes Technologies, 498 Washington 
Street, Coventry, Rhode Island 02816, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................     7370  I
Methylphenidate........................     1724  II
Oxycodone..............................     9143  II
Hydromorphone..........................     9150  II
Hydrocodone............................     9193  II
Morphine...............................     9300  II
Opium, Raw.............................     9600  II
Oxymorphone............................     9652  II
Poppy Straw Concentrate................     9670  II
------------------------------------------------------------------------

    The company plans to import Opium, Raw (9600), and Poppy Straw 
Concentrate (9670) in order to bulk manufacture controlled substances 
in Active Pharmaceutical Ingredient (API) form. The company distributes 
the manufactured APIs in bulk to its customers.
    The company plans to import the other listed controlled substances 
for internal reference standards use only. The comparisons of foreign 
reference standards to the company's domestically manufactured API will 
allow the company to export domestically manufactured API to foreign 
markets.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08539 Filed 4-23-21; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.